New York Life Investment Management LLC Has $4.35 Million Position in Xylem Inc. (NYSE:XYL)

New York Life Investment Management LLC cut its stake in Xylem Inc. (NYSE:XYL) by 1.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,453 shares of the industrial products company’s stock after selling 564 shares during the period. New York Life Investment Management LLC’s holdings in Xylem were worth $4,345,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of XYL. Heck Capital Advisors LLC acquired a new position in Xylem in the fourth quarter valued at about $36,000. Pathway Financial Advisers LLC lifted its holdings in shares of Xylem by 122.4% during the 4th quarter. Pathway Financial Advisers LLC now owns 318 shares of the industrial products company’s stock worth $37,000 after acquiring an additional 175 shares during the period. Assetmark Inc. boosted its position in shares of Xylem by 3,887.5% during the 3rd quarter. Assetmark Inc. now owns 319 shares of the industrial products company’s stock worth $43,000 after acquiring an additional 311 shares in the last quarter. Versant Capital Management Inc increased its stake in Xylem by 318.2% in the fourth quarter. Versant Capital Management Inc now owns 368 shares of the industrial products company’s stock valued at $43,000 after acquiring an additional 280 shares during the last quarter. Finally, Catalyst Capital Advisors LLC raised its position in Xylem by 226.0% during the third quarter. Catalyst Capital Advisors LLC now owns 339 shares of the industrial products company’s stock valued at $46,000 after purchasing an additional 235 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors.

Xylem Price Performance

XYL stock opened at $130.91 on Friday. The company has a market capitalization of $31.80 billion, a P/E ratio of 35.77, a PEG ratio of 2.33 and a beta of 1.07. The company has a fifty day moving average price of $122.87 and a 200-day moving average price of $127.20. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.33 and a current ratio of 1.76. Xylem Inc. has a 52-week low of $113.26 and a 52-week high of $146.08.

Xylem (NYSE:XYL) last announced its earnings results on Tuesday, February 4th. The industrial products company reported $1.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.12 by $0.06. Xylem had a return on equity of 9.96% and a net margin of 10.40%. The business had revenue of $2.30 billion during the quarter, compared to analyst estimates of $2.18 billion. During the same period last year, the company earned $0.99 EPS. Xylem’s revenue for the quarter was up 8.6% compared to the same quarter last year. As a group, equities analysts expect that Xylem Inc. will post 4.65 EPS for the current year.

Xylem Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 19th. Investors of record on Tuesday, February 18th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Tuesday, February 18th. This is a boost from Xylem’s previous quarterly dividend of $0.36. This represents a $1.60 annualized dividend and a yield of 1.22%. Xylem’s dividend payout ratio is presently 43.72%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on XYL shares. Citigroup downgraded Xylem from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 5th. Wolfe Research reiterated a “peer perform” rating on shares of Xylem in a research report on Thursday, December 12th. Robert W. Baird increased their target price on shares of Xylem from $139.00 to $148.00 and gave the stock an “outperform” rating in a report on Wednesday, February 5th. Stifel Nicolaus reduced their price target on shares of Xylem from $166.00 to $150.00 and set a “buy” rating on the stock in a research note on Friday, January 24th. Finally, TD Cowen lowered their price objective on shares of Xylem from $138.00 to $125.00 and set a “hold” rating for the company in a research report on Wednesday, November 6th. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $149.90.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.